- Report
- June 2024
- 200 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- January 2022
- 60 Pages
Global
From €3595EUR$3,950USD£3,082GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1820EUR$2,000USD£1,560GBP
The Mallory Weiss tear is a type of tear in the mucosal lining of the esophagus, which is caused by forceful vomiting. It is a common complication of gastroesophageal reflux disease (GERD) and is often seen in alcoholics. Treatment for Mallory Weiss tear typically involves medications to reduce stomach acid and promote healing of the tear. These medications are known as Gastrointestinal Drugs.
Gastrointestinal Drugs are used to treat a variety of conditions, including GERD, ulcers, and irritable bowel syndrome. Common medications used to treat Mallory Weiss tear include proton pump inhibitors (PPIs), H2 blockers, and antacids. These medications work by reducing the amount of acid in the stomach, which helps to promote healing of the tear.
The Mallory Weiss tear drug market is a growing segment of the Gastrointestinal Drugs market. Companies in this market include AstraZeneca, GlaxoSmithKline, Pfizer, Takeda, and Novartis. These companies offer a variety of medications to treat Mallory Weiss tear, including PPIs, H2 blockers, and antacids. Show Less Read more